Mesoblast Ltd (Mesoblast)

Oncology Corporate Profile

HQ Location

505 Fifth Avenue
Level 3
New York, NY 10017

Company Description

Mesoblast Ltd. is a world leader in developing innovative cellular medicines. They have established what they believe is the industry's most clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2. All their clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.


This company does not have any commercial products

This company does not have any pipeline products


Recent News Headlines

There are no news items to display